Slide parameters (0-100) for all five domains to visualize the IBS-SSS index.
Guidelines & Evidence
Clinical Details
Section 1
When to Use
When to Use
Quantification of symptoms in Irritable Bowel Syndrome (IBS) for clinical and research settings
To monitor therapeutic response across dietary, pharmacological, or psychological interventions
To aid in the subtyping of "severe" vs. "moderate" IBS during tertiary care referral
Clinical Target
The IBS-SSS captures the multifaceted nature of IBS, including pain frequency, pain intensity, abdominal distension, bowel habit satisfaction, and overall life interference.
Section 2
Formula & Logic
The 5 Visual Analogue Scales (VAS)
01
Abdominal Pain Intensity: Max 100 points.
02
Abdominal Pain Frequency: Number of days in the last 10 (Multiplied by 10).
03
Abdominal Distension/Bloating: Max 100 points.
04
Dissatisfaction with Bowel Habit: Max 100 points.
05
Interference with Quality of Life: Max 100 points.
Total Score Interpretation (0–500)
< 75
Healthy control / Clinical Remission
75–175
Mild IBS
175–300
Moderate IBS
> 300
Severe IBS
Clinically Meaningful Change
A decrease of ≥ 50 points in the total score is universally accepted as the threshold for a "Clinically Significant Improvement."
Section 3
Pearls/Pitfalls
Why IBS-SSS over Rome IV?
Rome IV is a "Diagnostic" instrument (binary: Yes/No diagnosis). IBS-SSS is a "Severity" instrument. A patient can meet Rome IV criteria for IBS but have a "Mild" IBS-SSS (e.g., score 120), suggesting they may not require aggressive pharmacological management.
The "Severe" Phenotype
Patients with a score > 300 (Severe IBS) frequently have significant psychological overlay, including anxiety, depression, or somatization. These patients are the most likely to benefit from gut-directed hypnotherapy or TCAs (Neuromodulators).
Clinical Pearls
The IBS-SSS has excellent "test-retest" reliability (~0.83), making it a stable metric for long-term follow-up
Dissatisfaction with bowel habit is often the highest-scoring domain in patients with IBS-C (Constipation-predominant)
The 50-point change threshold is more reliable for patient improvement than simple "Likert" scales of relief
Developed by Professor Peter Whorwell at Wythenshawe Hospital, Manchester. Whorwell is a pioneer in the biological understanding of IBS and gut-directed hypnotherapy. His goal was to move IBS from a "waste-basket" diagnosis toward a scientifically measurable clinical entity.
